9007-41-4; biochemical markers; biological markers; blood plasma; clinical aspects; coronavirus disease 2019; C-reactive protein; cytokines; detection; diagnosis; diagnostic techniques; diagnostic value; human diseases; indexes; intensive care; interleukin 6; pandemics; patients; predictive value; procalcitonin; severe infections; viral diseases; acute infections; man; Severe acute respiratory syndrome coronavirus 2; China; Hubei; APEC countries; East Asia; Asia; high Human Development Index countries; upper-middle income countries; Central Southern China; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; biomarkers; plasma (blood); People's Republic of China; clinical picture; Hopei; Hupei; critical care; SARS-CoV-2; viral infections